Ingevity Co. (NYSE:NGVT – Get Free Report) has earned a consensus recommendation of “Hold” from the six ratings firms that are covering the firm, MarketBeat reports. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $55.00.
NGVT has been the subject of several recent research reports. Wells Fargo & Company boosted their price target on Ingevity from $43.00 to $50.00 and gave the company an “equal weight” rating in a research note on Friday, February 23rd. BMO Capital Markets upped their target price on Ingevity from $50.00 to $55.00 and gave the company a “market perform” rating in a research report on Wednesday, May 8th. Oppenheimer raised their price target on Ingevity from $50.00 to $58.00 and gave the stock an “outperform” rating in a research report on Thursday, May 2nd. Jefferies Financial Group raised shares of Ingevity from a “hold” rating to a “buy” rating and upped their price objective for the stock from $52.00 to $62.00 in a research report on Monday, April 22nd. Finally, Loop Capital increased their price objective on shares of Ingevity from $49.00 to $56.00 and gave the stock a “hold” rating in a research note on Tuesday, May 7th.
Read Our Latest Analysis on Ingevity
Institutional Inflows and Outflows
Ingevity Stock Down 1.2 %
NGVT stock opened at $48.04 on Friday. The business’s fifty day moving average price is $49.33 and its two-hundred day moving average price is $46.12. The stock has a market capitalization of $1.75 billion, a price-to-earnings ratio of -15.45 and a beta of 1.72. Ingevity has a fifty-two week low of $36.66 and a fifty-two week high of $66.18. The company has a debt-to-equity ratio of 2.48, a current ratio of 1.90 and a quick ratio of 0.98.
Ingevity (NYSE:NGVT – Get Free Report) last released its quarterly earnings results on Wednesday, May 1st. The company reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.15. The business had revenue of $340.10 million for the quarter, compared to analyst estimates of $319.15 million. Ingevity had a negative net margin of 6.84% and a positive return on equity of 18.65%. Ingevity’s revenue for the quarter was down 13.4% compared to the same quarter last year. During the same period last year, the firm earned $1.09 earnings per share. On average, equities analysts anticipate that Ingevity will post 3.78 earnings per share for the current year.
About Ingevity
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
See Also
- Five stocks we like better than Ingevity
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- MarketBeat Week in Review – 6/3 – 6/7
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Geron Corporation: FDA Approval Fuels Stock Price Surge
- 3 Fintech Stocks With Good 2021 Prospects
- Intel’s Secret Plan for a Double-Digit Stock Rally Revealed
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.